CoV Biotechnology is an early-stage Singapore-based biotechnology company focusing on inducing broad, pan-sarbecovirus immune responses to address the evolving and mutating nature of the coronavirus. The company is developing booster vaccines and therapeutics that are effective against variants of SARS-2 beta coronavirus, to protect against future variants and future crossovers of related coronaviruses from animal to humans.
Company Details
- Founded
- 2022
- Address
- 79 Science Park Drive, Singapore,118264,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.covbiotech.com
- Keywords
- jobs.
- HQ
- Singapore
Cov Biotechnology Questions
Cov Biotechnology's website is http://www.covbiotech.com
Cov Biotechnology's LinkedIn profile is https://sg.linkedin.com/company/cov-biotechnology
Cov Biotechnology's industry is
Biotechnology Research
Cov Biotechnology's top competitors are
Straits Biotech Pte Ltd,
Engine Biosciences,
Veredus Laboratories,
Automera,
Biteback Biotechnology Pte. Ltd,
Polaris Partners,
I-Dna Biotechnology Pte Ltd,
Clavystbio,
Leyden Labs,
Chemt Biotechnology.
Cov Biotechnology's categories are Biotechnology Research
Cov Biotechnology's founding year is 2022
